COMDORA-SBN recommendations for patients with rare kidney diseases in relation to the Covid-19 pandemic
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Jornal Brasileiro de Nefrologia |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002020000500036 |
Resumo: | ABSTRACT During the Covid-19 pandemic, the issue is how to maintain adequate care for people with other diseases. In this document, the SBN Rare Diseases Committee (COMDORA) gives some guidelines on the care of patients with rare kidney diseases. These patients should follow the recommendations for the general population, bearing in mind that, as they have chronic kidney disease, they are included in the risk group for more serious outcomes if they develop Covid-19. Non-essential decision-making procedures should be postponed. In stable cases under appropriate treatment, we must choose to contact our patients remotely, using teleconsultations and home exam collections (if possible). In the presence of a symptom or sign of decompensation of the underlying disease, or infection with Sars-cov-2, advise the patient to seek medical assistance. The patient should not be waiting to get worse. Changes to the prescription should only be made on a scientific basis. Dosage suspension or change is not recommended, even in cases in which the patient needs to go to a center to receive his medication; in this case, the infusion center must follow the recommendations of the Ministry of Health. If the patient develops Covid-19 and uses any drugs, check the need for dose adjustment of the routine medications. Avoid the use of antimetabolics and anti-CD20 in patients with Covid-19, as they reduce viral clearance and predispose to bacterial infections. Contact between the patient and the medical team is essential; changes are recommended only with specialized medical guidance. |
id |
SBN-1_a5dce4e32ba9294b193ed4983490182a |
---|---|
oai_identifier_str |
oai:scielo:S0101-28002020000500036 |
network_acronym_str |
SBN-1 |
network_name_str |
Jornal Brasileiro de Nefrologia |
repository_id_str |
|
spelling |
COMDORA-SBN recommendations for patients with rare kidney diseases in relation to the Covid-19 pandemicChronic kidney diseaserare diseasesCovid-19Sars-cov-2ABSTRACT During the Covid-19 pandemic, the issue is how to maintain adequate care for people with other diseases. In this document, the SBN Rare Diseases Committee (COMDORA) gives some guidelines on the care of patients with rare kidney diseases. These patients should follow the recommendations for the general population, bearing in mind that, as they have chronic kidney disease, they are included in the risk group for more serious outcomes if they develop Covid-19. Non-essential decision-making procedures should be postponed. In stable cases under appropriate treatment, we must choose to contact our patients remotely, using teleconsultations and home exam collections (if possible). In the presence of a symptom or sign of decompensation of the underlying disease, or infection with Sars-cov-2, advise the patient to seek medical assistance. The patient should not be waiting to get worse. Changes to the prescription should only be made on a scientific basis. Dosage suspension or change is not recommended, even in cases in which the patient needs to go to a center to receive his medication; in this case, the infusion center must follow the recommendations of the Ministry of Health. If the patient develops Covid-19 and uses any drugs, check the need for dose adjustment of the routine medications. Avoid the use of antimetabolics and anti-CD20 in patients with Covid-19, as they reduce viral clearance and predispose to bacterial infections. Contact between the patient and the medical team is essential; changes are recommended only with specialized medical guidance.Sociedade Brasileira de Nefrologia2020-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002020000500036Brazilian Journal of Nephrology v.42 n.2 suppl.1 2020reponame:Jornal Brasileiro de Nefrologiainstname:Sociedade Brasileira de Nefrologia (SBN)instacron:SBN10.1590/2175-8239-jbn-2020-s109info:eu-repo/semantics/openAccessColares,Vinícius SardãoMiranda,Silvana MariaAndrade,Luis Gustavo Modelli dePalma,Lilian Monteiro PereiraCastro,Maria Cristina Ribeiro deSilva,Cassiano Augusto BragaPenido,Maria Goretti Moreira GuimarãesSobral,RobertaVaisbich,Maria Helenaeng2020-12-04T00:00:00Zoai:scielo:S0101-28002020000500036Revistahttp://www.bjn.org.br/ONGhttps://old.scielo.br/oai/scielo-oai.php||jbn@sbn.org.br2175-82390101-2800opendoar:2020-12-04T00:00Jornal Brasileiro de Nefrologia - Sociedade Brasileira de Nefrologia (SBN)false |
dc.title.none.fl_str_mv |
COMDORA-SBN recommendations for patients with rare kidney diseases in relation to the Covid-19 pandemic |
title |
COMDORA-SBN recommendations for patients with rare kidney diseases in relation to the Covid-19 pandemic |
spellingShingle |
COMDORA-SBN recommendations for patients with rare kidney diseases in relation to the Covid-19 pandemic Colares,Vinícius Sardão Chronic kidney disease rare diseases Covid-19 Sars-cov-2 |
title_short |
COMDORA-SBN recommendations for patients with rare kidney diseases in relation to the Covid-19 pandemic |
title_full |
COMDORA-SBN recommendations for patients with rare kidney diseases in relation to the Covid-19 pandemic |
title_fullStr |
COMDORA-SBN recommendations for patients with rare kidney diseases in relation to the Covid-19 pandemic |
title_full_unstemmed |
COMDORA-SBN recommendations for patients with rare kidney diseases in relation to the Covid-19 pandemic |
title_sort |
COMDORA-SBN recommendations for patients with rare kidney diseases in relation to the Covid-19 pandemic |
author |
Colares,Vinícius Sardão |
author_facet |
Colares,Vinícius Sardão Miranda,Silvana Maria Andrade,Luis Gustavo Modelli de Palma,Lilian Monteiro Pereira Castro,Maria Cristina Ribeiro de Silva,Cassiano Augusto Braga Penido,Maria Goretti Moreira Guimarães Sobral,Roberta Vaisbich,Maria Helena |
author_role |
author |
author2 |
Miranda,Silvana Maria Andrade,Luis Gustavo Modelli de Palma,Lilian Monteiro Pereira Castro,Maria Cristina Ribeiro de Silva,Cassiano Augusto Braga Penido,Maria Goretti Moreira Guimarães Sobral,Roberta Vaisbich,Maria Helena |
author2_role |
author author author author author author author author |
dc.contributor.author.fl_str_mv |
Colares,Vinícius Sardão Miranda,Silvana Maria Andrade,Luis Gustavo Modelli de Palma,Lilian Monteiro Pereira Castro,Maria Cristina Ribeiro de Silva,Cassiano Augusto Braga Penido,Maria Goretti Moreira Guimarães Sobral,Roberta Vaisbich,Maria Helena |
dc.subject.por.fl_str_mv |
Chronic kidney disease rare diseases Covid-19 Sars-cov-2 |
topic |
Chronic kidney disease rare diseases Covid-19 Sars-cov-2 |
description |
ABSTRACT During the Covid-19 pandemic, the issue is how to maintain adequate care for people with other diseases. In this document, the SBN Rare Diseases Committee (COMDORA) gives some guidelines on the care of patients with rare kidney diseases. These patients should follow the recommendations for the general population, bearing in mind that, as they have chronic kidney disease, they are included in the risk group for more serious outcomes if they develop Covid-19. Non-essential decision-making procedures should be postponed. In stable cases under appropriate treatment, we must choose to contact our patients remotely, using teleconsultations and home exam collections (if possible). In the presence of a symptom or sign of decompensation of the underlying disease, or infection with Sars-cov-2, advise the patient to seek medical assistance. The patient should not be waiting to get worse. Changes to the prescription should only be made on a scientific basis. Dosage suspension or change is not recommended, even in cases in which the patient needs to go to a center to receive his medication; in this case, the infusion center must follow the recommendations of the Ministry of Health. If the patient develops Covid-19 and uses any drugs, check the need for dose adjustment of the routine medications. Avoid the use of antimetabolics and anti-CD20 in patients with Covid-19, as they reduce viral clearance and predispose to bacterial infections. Contact between the patient and the medical team is essential; changes are recommended only with specialized medical guidance. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-01-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002020000500036 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002020000500036 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/2175-8239-jbn-2020-s109 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Nefrologia |
publisher.none.fl_str_mv |
Sociedade Brasileira de Nefrologia |
dc.source.none.fl_str_mv |
Brazilian Journal of Nephrology v.42 n.2 suppl.1 2020 reponame:Jornal Brasileiro de Nefrologia instname:Sociedade Brasileira de Nefrologia (SBN) instacron:SBN |
instname_str |
Sociedade Brasileira de Nefrologia (SBN) |
instacron_str |
SBN |
institution |
SBN |
reponame_str |
Jornal Brasileiro de Nefrologia |
collection |
Jornal Brasileiro de Nefrologia |
repository.name.fl_str_mv |
Jornal Brasileiro de Nefrologia - Sociedade Brasileira de Nefrologia (SBN) |
repository.mail.fl_str_mv |
||jbn@sbn.org.br |
_version_ |
1752122066102910976 |